Patrick W.

Executive director

San Francisco Bay Area

About

Experience

  • Executive Director, Clinical Development at Revolution Medicines
    Apr 2025 - Present · 1 yr 3 mos

  • Genentech (6 yrs 9 mos)
    • Senior Medical Director
      Apr 2022 - Apr 2025 · 3 yrs 1 mo

      Leading and developing studies evaluating novel treatments in oncology. Development lead for the tobemstomig (PD1-LAG3 bispecific) program and cross-indication immunotherapy in late stage oncology. Filing lead for atezolizumab SC formulation.

    • SSF PDOH Site Head
      Sep 2021 - Sep 2023 · 2 yrs 1 mo

      Representing clinical scientists and medical directors in PDOH, and working with PDOH and SSF site leadership to build community at Genentech.

    • Lead Medical Director
      Mar 2021 - Apr 2022 · 1 yr 2 mos

      Leading and developing studies evaluating novel treatments for patients with GU cancers.

  • Hematology and Oncology Fellow at MD Anderson Cancer Center
    Jul 2015 - May 2018 · 2 yrs 11 mos

    Practicing medicine and research in cancer immunology and immunotherapy

  • Resident Physician, Internal Medicine at University of Maryland Medical Center
    Jun 2013 - Jul 2015 · 2 yrs 2 mos

    Physician Scientist Track, Internal Medicine

  • Medical Student at McGil University
    Aug 2005 - Jun 2013 · 7 yrs 11 mos

    Combined MD PhD program at McGill University